XNAS
OMCL
Market cap1.58bUSD
Oct 08, Last price
34.83USD
1D
-1.08%
1Q
-22.46%
Jan 2017
2.74%
IPO
297.60%
Name
Omnicell Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Related entities
Subsidiaries (9)
AESYNT INCORPORATED
AESYNT S.R.L.
OMNICELL
OMNICELL B.V.
OMNICELL GMBH
OMNICELL INDIA PRIVATE LIMITED
OMNICELL LIMITED
OMNICELL SRL
AESYNT CANADA INC.
Key people
Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer · since 2002
Chief Financial Officer, Executive Vice President · since 2015
Nhat H. Ngo
Executive Vice President - Marketing, Strategy and Business Development · since 2018
Scott P. Seidelmann
Executive Vice President and Chief Commercial Officer · since 2018
Joseph B. Spears
Senior Vice President, Chief Accounting Officer, Corporate Controller · since 2019
Robin Gene Seim
Director · since 2019
Joanne B. Bauer
Independent Director · since 2014
Vance B. Moore
Independent Director · since 2012
Independent Director · since 2013
Gary S. Petersmeyer
Independent Director · since 2007
Bruce E. Scott
Independent Director · since 2019
Bruce D. Smith
Independent Director · since 2014
Sara J. White
Independent Director · since 2003
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
4220 NORTH FREEWAY
FORT WORTH, TX 76137
US
FORT WORTH, TX 76137
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||